Latest Articles

Host cell proteins can prove problematic for the development of novel biopharmaceuticals. This article will highlight some of the latest advances in host cell analysis strategies and how they are being implemented.

Insight into the history of human–pathogen interactions, how different societies responded to disease and the origin of pathogens supports our understanding of human health and evolution. We explore what we're still learning about ancient pathogens and diseases.

Drew Burch discusses how next-gen mRNA technology is one of the most valuable tools to combat and control disease outbreaks and why continued investment in this field is crucial for maintaining our pandemic preparedness.

A microbiome analysis study highlights that pandemic-related lifestyle changes may be responsible for alterations seen in the microbial profile of the small intestine before versus during the COVID-19 pandemic.

Bayesian statistics has emerged as a powerful methodology for making decisions from data in the applied sciences. Bayesian brings a new way of thinking to statistics, in how it deals with probability, uncertainty and drawing inferences from an analysis.

The gene therapy landscape is dynamic and constantly shifting. In this article, we will review major advances in disease modification for illnesses that presently still lack effective treatments, as well as some challenges and approaches to overcome them.

In this op-ed, Professor Michael S. Kinch argues that the only way we can the COVID-19 pandemic is "to mandate that all individuals are not merely vaccinated but remain up to date with boosters."

This article explores the importance of testing for liver-related autoantibodies to differentiate between three autoimmune liver diseases.

Biopharmaceuticals require careful analysis during research, development and manufacturing. In this article, we highlight some of the analytical techniques employed in biopharmaceutical analysis, and how the field is evolving to meet new challenges.

Professor Donald Ingber is responsible for developing human organ chips, which provide researchers with a window into inter-organ physiology and the body’s response to drugs, without animal testing. Technology Networks' invited Ingber to an Ask Me Anything session to answer your questions about this incredible technology.